Results 181 to 190 of about 105,927 (341)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection

, 2021
Jan Christoph Banck, Niklas Mueller, Sibylle C. Mellinghoff, Martin Thelen, Alessia Fraccaroli, Viktoria Blumenberg, Philipp Koehler, Wolfgang G. Kunz, Martina Rudelius, Florian Schrötzlmair, Marion Subklewe, Hans Schlößer, Johanna Tischer, Oliver A. Cornely, Lars H. Lindner, Michael von Bergwelt‐Baildon   +15 more
openalex   +1 more source

Safety evaluation of the food enzyme abstract aspergillopepsin I from the non‐genetically modified Aspergillus niger strain CCTCC M 2023234

EFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The food enzyme aspergillopepsin I (EC 3.4.23.18) is produced with the non‐genetically modified Aspergillus niger strain CCTCC M 2023234 by Suntaq International Limited. The food enzyme was free from viable cells of the production organism. The food enzyme is intended to be used in eight food manufacturing processes.
EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Henk Van Loveren, Laurence Vernis, Magdalena Andryszkiewicz, Yi Liu   +14 more
wiley   +1 more source

Safety evaluation of the food enzyme aspergillopepsin I from the genetically modified Trichoderma reesei strain DP‐Nzq40

EFSA Journal, Volume 24, Issue 1, January 2026.
Abstract The food enzyme aspergillopepsin I (EC 3.4.23.18) is produced with the genetically modified microorganismTrichoderma reesei strain DP‐Nzq40 by Danisco US Inc. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and its DNA.
EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Henk Van Loveren, Laurence Vernis, Jaime Aguilera, Magdalena Andryszkiewicz, Daniele Cavanna, Yi Liu   +16 more
wiley   +1 more source

Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient. [PDF]

, 1994
Anonymous, British Society for Antimicrobial Chemotherapy Working Party, Fan-Havard, Fox, Galgiani, Johnson, Kitchen, Korting, Korting, Korting, Laine, McCarthy, Ollert, Rogers, Samaranayake, Smith, Warnock, Willocks, Wit   +18 more
core   +1 more source

Invasive Aspergillosis [PDF]

Clinical Infectious Diseases, 1998
openaire   +4 more sources

Pulmonary aspergillosis in US Veterans with COVID-19: a nationwide, retrospective cohort study

Antimicrobial Stewardship & Healthcare Epidemiology
Background: COVID-associated pulmonary aspergillosis (CAPA) was described early in the pandemic as a complication of SARS-CoV-2. Data about incidence of aspergillosis and characteristics of affected patients after mid-2021 are limited.
Kaitlin Swinnerton, Nathanael R. Fillmore, Ikwo Oboho, Janet Grubber, Mary Brophy, Nhan V Do, Paul A Monach, Westyn Branch-Elliman   +7 more
doaj   +1 more source

Frequency and molecular epidemiology of Aspergillus isolated from patients with suspicion of respiratory fungal infection [PDF]

, 2019
Objective: The aim of this study was to determine the frequency of Aspergillus detected in respiratory samples from a cohort of patients with suspicion of fungal infection of the respiratory tract as well as to determine the susceptibility to azoles of ...
Oliveira, M., Sabino, R., Simões, H., Verissimo, C.   +3 more
core  

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Clinical Infectious Diseases, 2008
T. Walsh, E. Anaissie, D. Denning, R. Herbrecht, D. Kontoyiannis, K. Marr, V. Morrison, B. Segal, W. Steinbach, D. Stevens, J. V. van Burik, J. Wingard, T. Patterson   +12 more
semanticscholar   +1 more source

Angioinvasive aspergillosis mimicking giant cell arteritis in an 81-year-old man with jaw pain and vision loss [PDF]

, 2022
Romain Guemara, A. Pieren, Laure Brulhart   +2 more
openalex   +1 more source

COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants [PDF]

Pierre Bay, Étienne Audureau, Sébastien Préau, Raphaël Favory, Aurélie Guigon, Nicholas Heming, Elyanne Gault, Tài Pham, Amal Chaghouri, Matthieu Turpin, Laurence Morand‐Joubert, Sébastien Jochmans, A. Pitsch, Sylvie Meireles, Damien Contou, Amandine Henry, Adrien Joseph, Marie‐Laure Chaix, Fabrice Uhel, Damien Roux, Diane Descamps, Malo Emery, Claudio Garcia-Sanchez, David Levy, Sonia Burrel, Julien Mayaux, Antoine Kimmoun, Cédric Hartard, Frédéric Pène, Flore Rozenberg, Stéphane Gaudry, Ségolène Brichler, Antoine Guillon, Lynda Handala, Fabienne Tamion, Alice Moisan, Thomas Daix, Sébastien Hantz, Flora Delamaire, Vincent Thibault, Bertrand Souweine, Cécile Henquell, L Picard, Françoise Botterel, Christophe Rodriguez, Armand Mekontso Dessap, Jean–Michel Pawlotsky, Slim Fourati, Nicolas de Prost, the SEVARVIR investigators, Keyvan Razazi, Raphaël Bellaïche, Elie Azoulay, Jean-François Timsit, Guillaume Voiriot, Nina de Montmollin, Stéphane Marot, Maxime Gasperment, Tomas Urbina, Hafid Ait Oufella, Eric Maury Djeneba Bocar Fofana, Charles-Edouard Luyt, Djillali Annane, Ferhat Meziani, Louis-Marie Jandeaux, Samira Fafi-Kremer, Cédric Darreau, Jean Thomin, Anaïs Dartevel, Sylvie Larrat, Evelyne Schvoerer, Béatrice La Combe, Séverine Haouisee, Sami Hraeich, Pierre-Edouard Fournier, Philippe Colson, Emmanuel Canet, Berthe Marie Imbert, Guillaume Thiery, Sylvie Pillet, Rémy Coudroy, Nicolas Leveque, Clément Saccheri, Valérie Giordanengo, Kada Klouche, Edouard Tuaillon, Cécile Aubron, Adissa Tran, Jean-Marc Tadié, Jean-Christophe Plantier, Sophie Vallet   +90 more
openalex   +1 more source